Meagan C. Fitzpatrick

5.5k total citations · 2 hit papers
66 papers, 2.9k citations indexed

About

Meagan C. Fitzpatrick is a scholar working on Infectious Diseases, Modeling and Simulation and Epidemiology. According to data from OpenAlex, Meagan C. Fitzpatrick has authored 66 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Infectious Diseases, 31 papers in Modeling and Simulation and 24 papers in Epidemiology. Recurrent topics in Meagan C. Fitzpatrick's work include COVID-19 epidemiological studies (31 papers), Vaccine Coverage and Hesitancy (19 papers) and SARS-CoV-2 and COVID-19 Research (18 papers). Meagan C. Fitzpatrick is often cited by papers focused on COVID-19 epidemiological studies (31 papers), Vaccine Coverage and Hesitancy (19 papers) and SARS-CoV-2 and COVID-19 Research (18 papers). Meagan C. Fitzpatrick collaborates with scholars based in United States, Canada and Mali. Meagan C. Fitzpatrick's co-authors include Alison P. Galvani, Burton H. Singer, Seyed M. Moghadas, Pratha Sah, Abhishek Pandey, Affan Shoukat, Chad R. Wells, Lauren Ancel Meyers, Thomas N. Vilches and Jeffrey P. Townsend and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Communications.

In The Last Decade

Meagan C. Fitzpatrick

64 papers receiving 2.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Impact of Vaccination on Coronavirus Disease 2019 (COVID-19) Outbreaks in the United States

2021 348 citations Seyed M. Moghadas, Thomas N. Vilches et al. Clinical Infectious Diseases profile →
Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis

2021 263 citations Pratha Sah, Meagan C. Fitzpatrick et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Meagan C. Fitzpatrick United States	26	1.5k	1.1k	606	475	346	66	2.9k
Ashleigh R. Tuite Canada	29	1.2k 0.8×	1.3k 1.2×	990 1.6×	277 0.6×	498 1.4×	124	3.3k
Rosalind M. Eggo United Kingdom	26	1.5k 1.0×	1.6k 1.5×	766 1.3×	386 0.8×	577 1.7×	83	3.2k
Natalie E. Dean United States	27	1.7k 1.2×	1.7k 1.6×	602 1.0×	520 1.1×	477 1.4×	62	3.3k
Pratha Sah United States	24	925 0.6×	1.0k 0.9×	297 0.5×	305 0.6×	210 0.6×	39	2.4k
Abhishek Pandey United States	22	1.0k 0.7×	1.1k 1.0×	396 0.7×	206 0.4×	360 1.0×	62	2.3k
Christian L. Althaus Switzerland	30	1.4k 0.9×	1.3k 1.2×	621 1.0×	191 0.4×	532 1.5×	80	3.5k
Jonathan M. Read United Kingdom	28	1.2k 0.8×	1.5k 1.4×	1.1k 1.7×	230 0.5×	485 1.4×	93	3.4k
Robin N. Thompson United Kingdom	26	882 0.6×	1.3k 1.2×	471 0.8×	154 0.3×	406 1.2×	108	2.5k
Matthew Biggerstaff United States	30	1.4k 1.0×	1.6k 1.5×	1.6k 2.6×	340 0.7×	351 1.0×	81	4.0k
Eunha Shim South Korea	27	732 0.5×	1.0k 0.9×	486 0.8×	357 0.8×	437 1.3×	63	2.0k

Countries citing papers authored by Meagan C. Fitzpatrick

Since Specialization

Citations

This map shows the geographic impact of Meagan C. Fitzpatrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meagan C. Fitzpatrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meagan C. Fitzpatrick more than expected).

Fields of papers citing papers by Meagan C. Fitzpatrick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meagan C. Fitzpatrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meagan C. Fitzpatrick. The network helps show where Meagan C. Fitzpatrick may publish in the future.

Co-authorship network of co-authors of Meagan C. Fitzpatrick

This figure shows the co-authorship network connecting the top 25 collaborators of Meagan C. Fitzpatrick. A scholar is included among the top collaborators of Meagan C. Fitzpatrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meagan C. Fitzpatrick. Meagan C. Fitzpatrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pandey, Abhishek, Meagan C. Fitzpatrick, Burton H. Singer, & Alison P. Galvani. (2024). Mortality and morbidity ramifications of proposed retractions in healthcare coverage for the United States. Proceedings of the National Academy of Sciences. 121(18). e2321494121–e2321494121. 1 indexed citations

Wells, Chad R., Abhishek Pandey, Seyed M. Moghadas, et al.. (2024). Evaluation of Strategies for Transitioning to Annual SARS-CoV-2 Vaccination Campaigns in the United States. Annals of Internal Medicine. 177(5). 609–617. 3 indexed citations

Driscoll, Amanda J., Fadima Cheick Haidara, Milagritos D. Tapia, et al.. (2023). Antenatal, intrapartum and infant azithromycin to prevent stillbirths and infant deaths: study protocol for SANTE, a 2×2 factorial randomised controlled trial in Mali. BMJ Open. 13(8). e067581–e067581. 5 indexed citations

Baral, Ranju, Andrea G. Buchwald, James D. Campbell, et al.. (2023). Optimizing next-generation RSV prevention in Mali: A cost-effectiveness analysis of pediatric vaccination, maternal vaccination, and extended half-life monoclonal antibody immunoprophylaxis. SHILAP Revista de lepidopterología. 3(5). e0001432–e0001432. 7 indexed citations

Ortiz, Justin R., Steven M. Brunwasser, Flanon Coulibaly, et al.. (2023). Model-estimated impacts of pediatric respiratory syncytial virus prevention programs in Mali on asthma prevalence. SHILAP Revista de lepidopterología. 2(2). 100092–100092. 1 indexed citations

Moghadas, Seyed M., Affan Shoukat, Joanne M. Langley, et al.. (2023). Cost-effectiveness of Prefusion F Protein-based Vaccines Against Respiratory Syncytial Virus Disease for Older Adults in the United States. Clinical Infectious Diseases. 78(5). 1328–1335. 22 indexed citations

Fitzpatrick, Meagan C., Ranju Baral, Amanda J. Driscoll, et al.. (2023). Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost effectiveness in low- and middle-income countries, April 7–8, 2022. Vaccine. 41(48). 7047–7059. 11 indexed citations

Du, Zhanwei, Lin Wang, Yuan Bai, et al.. (2022). Cost-effective proactive testing strategies during COVID-19 mass vaccination: A modelling study. The Lancet Regional Health - Americas. 8. 100182–100182. 10 indexed citations

Savinkina, Alexandra, Alyssa Bilinski, Meagan C. Fitzpatrick, et al.. (2022). Estimating deaths averted and cost per life saved by scaling up mRNA COVID-19 vaccination in low-income and lower-middle-income countries in the COVID-19 Omicron variant era: a modelling study. BMJ Open. 12(9). e061752–e061752. 24 indexed citations

10.

Sah, Pratha, Meagan C. Fitzpatrick, Elaheh Abdollahi, et al.. (2021). Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis. Proceedings of the National Academy of Sciences. 118(34). 263 indexed citations breakdown →

11.

Moghadas, Seyed M., Thomas N. Vilches, Kevin Zhang, et al.. (2021). The Impact of Vaccination on Coronavirus Disease 2019 (COVID-19) Outbreaks in the United States. Clinical Infectious Diseases. 73(12). 2257–2264. 348 indexed citations breakdown →

12.

Du, Zhanwei, Abhishek Pandey, Yuan Bai, et al.. (2021). Comparative cost-effectiveness of SARS-CoV-2 testing strategies in the USA: a modelling study. The Lancet Public Health. 6(3). e184–e191. 97 indexed citations

13.

Ortiz, Justin R., Joanie Robertson, Amanda J. Driscoll, et al.. (2021). The potential effects of deploying SARS-Cov-2 vaccines on cold storage capacity and immunization workload in countries of the WHO African Region. Vaccine. 39(15). 2165–2176. 9 indexed citations

14.

Galvani, Alison P., et al.. (2020). The imperative for universal healthcare to curtail the COVID-19 outbreak in the USA. EClinicalMedicine. 23. 100380–100380. 16 indexed citations

15.

Fitzpatrick, Meagan C., Abhishek Pandey, Chad R. Wells, Pratha Sah, & Alison P. Galvani. (2020). Buyer beware: inflated claims of sensitivity for rapid COVID-19 tests. The Lancet. 397(10268). 24–25. 21 indexed citations

16.

Sah, Pratha, Jan Medlock, Meagan C. Fitzpatrick, Burton H. Singer, & Alison P. Galvani. (2018). Optimizing the impact of low-efficacy influenza vaccines. Proceedings of the National Academy of Sciences. 115(20). 5151–5156. 34 indexed citations

17.

Fitzpatrick, Meagan C., Hiral Shah, Abhishek Pandey, et al.. (2016). One Health approach to cost-effective rabies control in India. Proceedings of the National Academy of Sciences. 113(51). 14574–14581. 65 indexed citations

18.

Scarpino, Samuel V., et al.. (2016). Epidemiological and Economic Effects of Priming With the Whole-CellBordetella pertussisVaccine. JAMA Pediatrics. 170(5). 459–459. 15 indexed citations

19.

Fitzpatrick, Meagan C., Katie Hampson, Sarah Cleaveland, et al.. (2012). Potential for Rabies Control through Dog Vaccination in Wildlife-Abundant Communities of Tanzania. PLoS neglected tropical diseases. 6(8). e1796–e1796. 46 indexed citations

20.

Fitzpatrick, Meagan C. & X. Bonnefoy. (1998). Environmental health services in Europe 3. Professional profiles.. PubMed. 82. iii–viii, 1. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact